Matei D - Search Results

1

Identification and characterization of ovarian cancer-initiating cells from primary human tumors.

Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP. Zhang S, et al. Among authors: matei d. Cancer Res. 2008 Jun 1;68(11):4311-20. doi: 10.1158/0008-5472.CAN-08-0364. Cancer Res. 2008. PMID: 18519691 Free PMC article.

2

Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation.

Matei D, Chang DD, Jeng MH. Matei D, et al. Clin Cancer Res. 2004 Jan 15;10(2):681-90. doi: 10.1158/1078-0432.ccr-0754-03. Clin Cancer Res. 2004. PMID: 14760091

3

Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer.

Chan MW, Wei SH, Wen P, Wang Z, Matei DE, Liu JC, Liyanarachchi S, Brown R, Nephew KP, Yan PS, Huang TH. Chan MW, et al. Clin Cancer Res. 2005 Oct 15;11(20):7376-83. doi: 10.1158/1078-0432.CCR-05-1100. Clin Cancer Res. 2005. PMID: 16243810

4

Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.

Matei D, Emerson RE, Lai YC, Baldridge LA, Rao J, Yiannoutsos C, Donner DD. Matei D, et al. Oncogene. 2006 Mar 30;25(14):2060-9. doi: 10.1038/sj.onc.1209232. Oncogene. 2006. PMID: 16331269

5

Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.

Satpathy M, Cao L, Pincheira R, Emerson R, Bigsby R, Nakshatri H, Matei D. Satpathy M, et al. Among authors: matei d. Cancer Res. 2007 Aug 1;67(15):7194-202. doi: 10.1158/0008-5472.CAN-07-0307. Cancer Res. 2007. PMID: 17671187

6

Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trial.

Matei D, Emerson RE, Schilder J, Menning N, Baldridge LA, Johnson CS, Breen T, McClean J, Stephens D, Whalen C, Sutton G. Matei D, et al. Cancer. 2008 Aug 15;113(4):723-32. doi: 10.1002/cncr.23605. Cancer. 2008. PMID: 18618737 Free article. Clinical Trial.

7

Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity.

Satpathy M, Shao M, Emerson R, Donner DB, Matei D. Satpathy M, et al. Among authors: matei d. J Biol Chem. 2009 Jun 5;284(23):15390-9. doi: 10.1074/jbc.M808331200. Epub 2009 Mar 26. J Biol Chem. 2009. PMID: 19324884 Free PMC article.

8

Minireview: epigenetic changes in ovarian cancer.

Balch C, Fang F, Matei DE, Huang TH, Nephew KP. Balch C, et al. Endocrinology. 2009 Sep;150(9):4003-11. doi: 10.1210/en.2009-0404. Epub 2009 Jul 2. Endocrinology. 2009. PMID: 19574400 Free PMC article. Review.

9

Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial.

Matei D, Schilder J, Sutton G, Perkins S, Breen T, Quon C, Sidor C. Matei D, et al. Gynecol Oncol. 2009 Oct;115(1):90-96. doi: 10.1016/j.ygyno.2009.05.042. Epub 2009 Jul 4. Gynecol Oncol. 2009. PMID: 19577796 Clinical Trial.

10

Epigenetic therapies for chemoresensitization of epithelial ovarian cancer.

Matei DE, Nephew KP. Matei DE, et al. Gynecol Oncol. 2010 Feb;116(2):195-201. doi: 10.1016/j.ygyno.2009.09.043. Epub 2009 Oct 24. Gynecol Oncol. 2010. PMID: 19854495 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters